Blackstone seals deal to acquire AYUMI Pharmaceutical: A strategic move in Japan’s pharma market
Global investment firm Blackstone has announced the acquisition of AYUMI Pharmaceutical, a leading Japanese specialty pharma company, marking its first controlling private equity investment in Japan. The deal was made through Blackstone-managed private equity funds, though the purchase price remains undisclosed. Blackstone’s Strategic Move into Japan’s Pharma Sector Blackstone’s acquisition of AYUMI Pharmaceutical represents a […]